Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced the completion of the initial phase of investment at its site in Dudley, UK to create the company’s centre of excellence for research into commercial applications of continuous flow chemistry. Announcement of the investment follows the appointment of Professor Ian R. Baxendale to lead a dedicated team of chemists and engineers to specialise in this area. Multiple flow chemistry platforms have been installed into a research laboratory at the site to allow the investigation of a wide range of chemical processes, including photolysis, electrochemistry and hydrogenations, as well
The post Sterling Pharma Solutions Establishes Centre of Excellence in Continuous Flow Chemistry appeared first on Pharma Mirror Magazine.
